Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings…
CoinDesk Overnight Rates (CDOR) to Support Stablecoin Money Markets based on Aave
These first-of-kind money market rates transform Aave pool activity into conventional overnight…
Vantage Foundation Strengthens Social Impact Agenda at UK-GCC Private Capital Alliance Summit
LONDON, June 12, 2025 /PRNewswire/ -- As part of its expanding global…
Energize Capital raises $430 million to capitalize and scale digitally-enabled climate solutions
Backed by leading institutional Limited Partners, Ventures Fund III underscores the need…
Monarq Asset Management Announces Strategic Investment From FalconX
NEW YORK, June 2, 2025 /PRNewswire/ -- Monarq Asset Management ("Monarq"), a…